Sensitive Determination of Onco-metabolites of D-and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Cheng, Qing Yun ^a   Xiong, Jun ^a   Huang, Wei ^a   Ma, Qin ^b   Ci, Weimin ^b   Feng, Yu Qi ^a   Yuan, Bi Feng ^a  

^a WUHAN UNIVERSITY   (China)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-HYDROXYGLUTARATE; GLUTARIC ACID DERIVATIVE;

ELECTROSPRAY MASS SPECTROMETRY; HUMAN; KIDNEY CARCINOMA; LIQUID CHROMATOGRAPHY; METABOLISM; METABOLOME; METABOLOMICS; NEOPLASM; PROCEDURES; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINE;

CARCINOMA, RENAL CELL; CHROMATOGRAPHY, LIQUID; GLUTARATES; HUMANS; METABOLOME; METABOLOMICS; NEOPLASMS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84944097106     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15217     Document Type: Article

References (37)

1. Locasale, J. W., Cantley, L. C. Metabolic flux and the regulation of mammalian cell growth. Cell Metab 14, 443-451 (2011).
2. Ladurner, A. G. Rheostat control of gene expression by metabolites. Mol Cell 24, 1-11 (2006).
3. Garber, K. Energy deregulation: licensing tumors to grow. Science 312, 1158-1159 (2006).
4. Wang, F. et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 340, 622-626 (2013).
5. Lokody, I. Metabolism: IDH2 drives cancer in vivo. Nat Rev Cancer 13, 756-757 (2013).
6. Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744 (2009).
7. Ward, P. S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225-234 (2010).
8. Loenarz, C., Schofield, C. J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem Sci 36, 7-18 (2011).
9. Struys, E. A. 2-Hydroxyglutarate is not a metabolite; D-2-hydroxyglutarate and L-2-hydroxyglutarate are! Proc Natl Acad Sci USA 110, E4939 (2013).
10. Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-U752 (2009).
11. Wang, J. H. et al. Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China. Proc Natl Acad Sci USA 110, 17017-17022 (2013).
12. Saha, S. K. et al. Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer. Nature 513, 110-114 (2014).
13. Gross, S. et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 207, 339-344 (2010).
14. Sellner, L. et al. Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations. Eur J Haematol 85, 457-459 (2010).
15. Janin, M. et al. Serum 2-hydroxyglutarate production in IDH1-and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group. J Clin Oncol 32, 297-305 (2014).
16. Seijo-Martinez, M. et al. L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings. Arch Neurol 62, 666-670 (2005).
17. Kranendijk, M. et al. Evidence for Genetic Heterogeneity in D-2-Hydroxyglutaric Aciduria. Human Mutation 31, 279-283 (2010).
18. Rashed, M. S., AlAmoudi, M., Aboul-Enein, H. Y. Chiral liquid chromatography tandem mass spectrometry in the determination of the configuration of 2-hydroxyglutaric acid in urine. Biomed Chromatogr 14, 317-320 (2000).
19. Chalmers, R. A. et al. D-2-hydroxyglutaric aciduria: case report and biochemical studies. J Inherit Metab Dis 3, 11-15 (1980).
20. Yang, J. et al. Enantioselective determination of trantinterol in rat plasma by ultra performance liquid chromatographyelectrospray ionization mass spectrometry after derivatization. Talanta 79, 1204-1208 (2009).
21. Liu, X. W., Zhang, Y. Y., Yuan, M., Sun, Y. X. Determination of naftopidil enantiomers in rat plasma using chiral solid phases and pre-column derivatization high-performance liquid chromatography. J Chromatogr B 907, 140-145 (2012).
22. Scheijen, J. L. et al. L(+ ) and D(? ) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+ ) and D(? ) lactate by reversed-phase liquid chromatography tandem mass spectrometry. Exp Diabetes Res 2012, 234812 (2012).
23. Huang, Y. Q., Ruan, G. D., Liu, J. Q., Gao, Q., Feng, Y. Q. Use of isotope differential derivatization for simultaneous determination of thiols and oxidized thiols by liquid chromatography tandem mass spectrometry. Anal Biochem 416, 159-166 (2011).
24. Chu, J. M. et al. Metal Oxide-Based Selective Enrichment Combined with Stable Isotope Labeling-Mass Spectrometry Analysis for Profiling of Ribose Conjugates. Anal Chem 87, 7364-7372 (2015).
25. Zhou, R., Guo, K., Li, L. 5-Diethylamino-naphthalene-1-sulfonyl chloride (DensCl): a novel triplex isotope labeling reagent for quantitative metabolome analysis by liquid chromatography mass spectrometry. Anal Chem 85, 11532-11539 (2013).
26. Alberice, J. V. et al. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach. J Chromatogr A 1318, 163-170 (2013).
27. Shen, L., Song, C. X., He, C., Zhang, Y. Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu Rev Biochem 83, 585-614 (2014).
28. Yuan, B. F., Feng, Y. Q. Recent advances in the analysis of 5-methylcytosine and its oxidation products. TrAC-Trend Anal Chem 54, 24-35 (2014).
29. Yuan, B. F. 5-Methylcytosine and Its Derivatives. Adv Clin Chem 67, 151-187 (2014).
30. Chen, M. L. et al. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry. Clin chem 59, 824-832 (2013).
31. Tang, Y., Zheng, S. J., Qi, C. B., Feng, Y. Q., Yuan, B. F. Sensitive and simultaneous determination of 5-methylcytosine and its oxidation products in genomic DNA by chemical derivatization coupled with liquid chromatography-tandem mass spectrometry analysis. Anal Chem 87, 3445-3452 (2015).
32. Jin, S. G. et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 71, 7360-7365 (2011).
33. Haffner, M. C. et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2, 627-637 (2011).
34. Liu, J. F., Yuan, B. F., Feng, Y. Q. Determination of hexanal and heptanal in human urine using magnetic solid phase extraction coupled with in-situ derivatization by high performance liquid chromatography. Talanta 136, 54-59 (2015).
35. Jiang, H. P., Qi, C. B., Chu, J. M., Yuan, B. F., Feng, Y. Q. Profiling of cis-Diol-containing Nucleosides and Ribosylated Metabolites by Boronate-affinity Organic-silica Hybrid Monolithic Capillary Liquid Chromatography/Mass Spectrometry. Sci Rep 5, 7785 (2015).
36. Akbay, E. A. et al. D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice. Genes Dev 28, 479-490 (2014).
37. Tolosa, J. M., Schjenken, J. E., Civiti, T. D., Clifton, V. L., Smith, R. Column-based method to simultaneously extract DNA, RNA, and proteins from the same sample. Biotechniques 43, 799-804 (2007).